Valirx (VAL)

 

Latest News

ValiRx obtains new US patent allowance

ValiRx said its joint venture with Tangent Reprofiling has obtained a new US patent allowance. The clinical stage therapeu...

Notification of US Patent Allowance

RNS Number: 2470T ValiRx PLC 11 October 2017 VALIRX PLC ("ValiRx", the "Company" or the "Group") NOTIFICATION OF US PATENT ALLOWANCE FOR THERAPEUTIC COMPOUND, VAL401 London, UK ., 11 October 2017: ValiRx Plc (AIM: VAL), the clinical stage biotechnology company , is pleased to report that ValiSeek Limited ("ValiSeek"), the join...

Holding(s) in Company

RNS Number: 7448S ValiRx PLC 05 October 2017 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: ValiRx PLC 1b. Please ind...

Total Voting Rights

RNS Number: 1466S ValiRx PLC 02 October 2017 Va li R x P lc ("ValiRx" or "the Company" or "the Group") Total Voting Rights The Company announces that the total number of ordinary shares of 0.1 pence each of the Company at the date of this notice is 203,958,937 with each share carrying the right to one vote. There are no shares held in Treasury. The total num...

All News

DateHeadlineSource
11-10-17ValiRx obtains new US patent allowanceStockMarketWire
11-10-17Notification of US Patent AllowanceRNS
05-10-17Holding(s) in CompanyRNS
02-10-17Total Voting RightsRNS
28-09-17ValiRx cancer treatment JV progressing wellStockMarketWire
28-09-17ValiSeek Clinical Development UpdateRNS
28-09-17ValiRx - Valiseek Clinical Development UpdateBRR Media
27-09-17Holding(s) in CompanyRNS
26-09-17ValiRx interim loss narrowsStockMarketWire
26-09-17Half-year ReportRNS
26-09-17ValiRx - Half-year Report 2017BRR Media
20-09-17VAL201 updateRNS
19-09-17Issue of EquityRNS
13-09-17Hardman Research: GeneICE and VAL101 progressRNS
07-09-17ValiRx reports good progress in developing GeneICE technology platformStockMarketWire
07-09-17GeneICE & VAL101 UpdateRNS
07-09-17ValiRx - GeneICE & VAL101 UpdateBRR Media
11-08-17Convertible Loan FacilityRNS
02-08-17Conversion of Loan NoteRNS
28-07-17ValiRx signs first product licensing agreementStockMarketWire
28-07-17Licencing AgreementRNS
22-06-17Formation of & Appointments to an Advisory BoardRNS
15-06-17ValiSeek Development Update - Recruitment ClosesRNS
15-06-17ValiRx - ValiSeek Clinical Development UpdateBRR Media
01-06-17ValiRx updates on Yorkville CLN ConversionStockMarketWire
01-06-17Yorkville CLN ConversionRNS
31-05-17Hardman Research:Developing novel cancer therapiesRNS
30-05-17All resolutions passed at AGM of ValiRxStockMarketWire
30-05-17Result of AGMRNS
24-05-17ValiSeek's patent allowed in AustraliaStockMarketWire
24-05-17NOTIFICATION OF AUSTRALIAN PATENT ALLOWANCERNS
08-05-17Broker Forecast - Beaufort Securities issues a broker note on ValiRx PLCStockMarketWire
08-05-17ValiRx - Final Results BRR Media
05-05-17Notice of AGMRNS
05-05-17ValiRx widens FY pretax loss from continuing ops.StockMarketWire
05-05-17Final ResultsRNS
27-04-17Re: SHARES Magazine Supplement on ValiRx websiteRNS
19-04-17Change of Registered OfficeRNS
15-03-17Director Deals - ValiRx PLC (VAL)StockMarketWire
15-03-17Director Deals - ValiRx PLC (VAL)StockMarketWire

RSS feeds

  • Editorial news feed for LSE:VAL Editorial
  • Regulatory news feed for LSE:VAL Regulatory